申请人:Université de la Côte d'Azur
公开号:EP4306109A1
公开(公告)日:2024-01-17
Compound with the following formula I:
wherein
- R1 represents O or NH,
- R2 represents a linear, branched or cyclic alkyl comprising from 1 to 8 carbon atoms, possibly interrupted by a group selected from -O-, -S-, -(C=O)-, NH and possibly being substituted by one or more halogens;
an alkylene comprising from 1 to 8 carbon atoms and possibly being substituted by one or more halogens,
a phenyl or an arylene,
- R3, R4 and R5 represent independently -H, a halogen, a linear or branched alkyl comprising from 1 to 8 carbon atoms, possibly being substituted by one or more halogens, CN, -NO2, OX1 with X1 being selected from -H, linear or branched alkyl comprising from 1 to 8 carbon atoms, possibly being substituted by one or more halogens, COOR6, OCOR6, SO2NR6R7, NR6R7, NR6COR7, or OR6, with R6 and R7 being identical or different and R6 and R7 representing H or an alkyl comprising from 1 to 8 carbon atoms,
and its use as a medicament.
结构式为I的化合物:
其中,
- R1 表示O或NH,
- R2 表示一个线性、支链或环状的烷基,包含1到8个碳原子,可能被选自-O-、-S-、-(C=O)-、NH的一个基团打断,并且可能被一个或多个卤素取代;
可能被一个或多个卤素取代的包含1到8个碳原子的烷基;
苯基或芳基;
- R3、R4 和 R5 独立地表示-H、一个卤素、一个包含1到8个碳原子的线性或支链烷基(可能被一个或多个卤素取代)、CN、-NO2、OX1(其中X1表示-H、一个包含1到8个碳原子的线性或支链烷基,可能被一个或多个卤素取代)、COOR6、OCOR6、SO2NR6R7、NR6R7、NR6COR7、或OR6,其中R6和R7代表相同的或不同的基团且R6和R7表示H或一个包含1到8个碳原子的烷基;
以及将其用作药物的用途。